Table 2.
Correlation between plasma DD, FIB, PLT levels and patient/tumor characteristics in OSCC cases
| Variables | Preoperative DD (μg/L) | Preoperative FIB (g/L) | Preoperative PLT (10^9/L) |
||||||
|---|---|---|---|---|---|---|---|---|---|
| <500 | ≥500 | P | <3.33 | ≥3.33 | P | <259.5 | ≥259.5 | P | |
| Sex | 0.187 | 0.025 | 0.114 | ||||||
| Male | 105 | 43 | 51 | 97 | 78 | 63 | |||
| Female | 34 | 20 | 28 | 26 | 40 | 21 | |||
| Age | 0.062 | 0.070 | 0.415 | ||||||
| <60 | 92 | 33 | 55 | 70 | 70 | 53 | |||
| ≥ 60 | 47 | 30 | 24 | 53 | 47 | 32 | |||
| Tumor site | 0.040 | 0.387 | 0.048 | ||||||
| Tongue | 74 | 19 | 42 | 51 | 58 | 28 | |||
| Buccal mucosa | 18 | 15 | 12 | 21 | 18 | 11 | |||
| Gingiva | 23 | 17 | 13 | 27 | 22 | 25 | |||
| Floor of mouth | 14 | 4 | 8 | 10 | 11 | 9 | |||
| Palate | 4 | 4 | 1 | 7 | 1 | 7 | |||
| Lip | 2 | 2 | 2 | 2 | 1 | 1 | |||
| Neck (LN) | 4 | 2 | 1 | 5 | 6 | 4 | |||
| T stage | 0.000 | 0.129 | 0.194 | ||||||
| T1(primary) | 26 | 3 | 14 | 15 | 15 | 9 | |||
| T2(primary) | 39 | 14 | 21 | 32 | 36 | 16 | |||
| T3(primary) | 23 | 3 | 11 | 15 | 14 | 7 | |||
| T4(primary) | 30 | 17 | 22 | 25 | 30 | 28 | |||
| Relapse | 21 | 26 | 11 | 36 | 23 | 24 | |||
| N stage | 0.001 | 0.002 | 0.167 | ||||||
| N0(Primary) | 75 | 20 | 34 | 61 | 56 | 28 | |||
| N+(Primary) | 43 | 17 | 34 | 26 | 39 | 32 | |||
| N0(Relapse) | 12 | 16 | 9 | 19 | 15 | 13 | |||
| N+(Relapse) | 9 | 10 | 2 | 17 | 8 | 11 | |||
| Clinical stage | 0.000 | 0.094 | 0.040 | ||||||
| I | 22 | 3 | 11 | 14 | 14 | 3 | |||
| II | 30 | 10 | 15 | 25 | 27 | 10 | |||
| III | 21 | 4 | 10 | 15 | 13 | 12 | |||
| IV | 45 | 20 | 32 | 33 | 41 | 35 | |||
| Relapse | 21 | 26 | 11 | 36 | 23 | 24 | |||
| Primary/Relapse | 0.000 | 0.012 | 0.113 | ||||||
| Primary | 118 | 37 | 68 | 87 | 96 | 59 | |||
| Relapse | 21 | 26 | 11 | 36 | 23 | 24 | |||